טוען...
Molecular Targeting and Rational Chemotherapy in Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a molecularly complex disease with multiple aberrant genetic pathways involved in its pathogenesis. Approximately one-third to one-half of patients with AML would relapse, and no standard therapy is established for relapsing and/or refractory AML (RR-AML) yet. It is u...
שמור ב:
| הוצא לאור ב: | J Exp Pharmacol |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dove
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7269636/ https://ncbi.nlm.nih.gov/pubmed/32581600 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JEP.S254334 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|